In clinical trials of semaglutide for type 2 diabetes mellitus, patients exposed to semaglutide subcutaneous injection reported increases in amylase (hyperamylasemia) and lipase, and had a mean increase from baseline in amylase of 13% and lipase of 22%
Framing the conversation around absolute risk, which stays low for any individual even when the relative risk looks large, keeps it accurate
Phase 3 updates (topline sponsor communications) Sponsor press releases have also shared Phase 3 topline updates (for example, TRIUMPH-4)
For tendinopathy or partial tears
Gao, Xy., Hou, F., Zhang, Zp
Why does the water have to run down the side of the vial